2040: AI as a Co-Clinician in the NHS
- Lloyd Price
- Apr 26
- 6 min read

The integration of AI as a co-clinician within the UK’s National Health Service (NHS) over the next 15 years (by 2040) holds immense potential to address systemic challenges like workforce shortages, rising demand, and budget constraints while enhancing patient care.
However, the NHS’s unique structure, centralised, publicly funded, and serving a diverse population, presents specific opportunities and hurdles.
So how could AI evolve as a co-clinician within the NHS,?
Context: The NHS Landscape
Current State: The NHS uses fragmented EHR systems (e.g., Cerner, Epic, SystmOne) across trusts, with varying levels of digitization. The NHS Long Term Plan (2019) and subsequent policies emphasize digital transformation, interoperability, and AI adoption.
Challenges: Aging population, staff burnout, long waiting lists, and limited funding (NHS budget ~£190 billion in 2024/25) constrain innovation. Data privacy under GDPR and NHS-specific regulations is a priority.
Opportunities: Centralized governance allows scalable AI deployment. The NHS’s vast dataset (e.g., 66 million patients) is a goldmine for training AI models.
Evolution of AI as a Co-Clinician in the NHS (2025–2040)
Short-Term (2025–2030): Foundational Integration
AI will begin as a supportive tool within EHRs, focusing on efficiency and targeted clinical support.
Enhanced EHR Integration:
Interoperable Systems: The NHS’s push for Integrated Care Systems (ICSs) will drive adoption of FHIR-based EHRs, unifying data from GP practices, hospitals, and community care. AI will analyse this data for real-time insights.
Example: SystmOne and EMIS Web, used by most GPs, will embed AI modules to flag high-risk patients (e.g., those with undiagnosed hypertension) based on routine vitals and history.
NHS-Specific Tools: The NHS AI Lab (launched 2020) will pilot AI-driven EHR plugins, such as predictive models for A&E admissions.
Clinical Decision Support:
Diagnostic Aids: AI will assist in radiology, pathology, and primary care. For instance, AI tools like those from Qure.ai could analyse chest X-rays for pneumonia, reducing radiologist workload.
Triage and Referral: AI will streamline GP referrals by prioritising urgent cases (e.g., suspected cancer) using risk scores from EHR data.
Case Study: Moorfields Eye Hospital’s collaboration with DeepMind (now Google Health) already uses AI to detect diabetic retinopathy, a model likely to expand to other specialties.
Administrative Automation:
NLP for Documentation: AI will transcribe and summarize GP consultations or hospital rounds, reducing time spent on notes. Pilots like Nuance’s Dragon Medical are already in use.
Resource Allocation: AI will predict patient flow in A&E, optimising staff schedules and bed availability.
Key Enablers:
NHS Digital Investments: The £2 billion Digital Transformation Fund (2022–2025) will upgrade infrastructure, enabling cloud-based AI deployment.
Workforce Training: Programs like the NHS Digital Academy will train clinicians to use AI tools effectively.
Regulatory Framework: The Medicines and Healthcare products Regulatory Agency (MHRA) will refine AI-as-a-medical-device guidelines, ensuring safe adoption.
Key Challenges:
Fragmented EHRs across trusts hinder data sharing.
Staff resistance due to time constraints and skepticism about AI reliability.
Budget limitations may prioritise immediate needs over long-term AI investment.
Mid-Term (2030–2035): AI as a Collaborative Partner
AI will evolve into a proactive co-clinician, deeply integrated into clinical workflows and patient care pathways.
Advanced Clinical Support:
Predictive Analytics: AI will identify at-risk patients across ICSs, e.g., predicting heart failure risk using GP records, wearable data, and social determinants like deprivation indices.
Personalised Care: AI will tailor treatment plans, such as recommending specific antidepressants based on patient history and genetic data available via the NHS Genomic Medicine Service.
Example: An AI co-clinician could alert a GP to a patient’s rising HbA1c levels, suggesting a diabetes prevention program and scheduling a follow-up.
Population Health Management:
Public Health Insights: AI will aggregate anonymised EHR data to monitor disease trends, supporting campaigns like flu vaccinations or cancer screenings.
Pandemic Preparedness: Building on COVID-19 lessons, AI will model outbreak risks and optimize resource allocation (e.g., ventilators, staff).
NHS Case: The NHS Healthier Together platform could integrate AI to target interventions in high-deprivation areas.
Patient Engagement:
NHS App Integration: The NHS App (used by 30 million+ in 2024) will evolve into a patient-facing AI interface, offering personalised health advice, appointment reminders, and data-sharing controls.
Wearable Syncing: AI will analyse data from devices like smartwatches to provide early warnings (e.g., atrial fibrillation detection), feeding into EHRs.
System-Wide Efficiency:
Waiting List Reduction: AI will optimise elective surgery schedules by predicting no-shows or complications, addressing backlogs (e.g., 7.6 million waiting list in 2024).
Telemedicine Support: AI will enhance virtual wards, monitoring patients at home and escalating cases to clinicians when needed.
Key Enablers:
Data Trusts: NHS England’s Secure Data Environments (SDEs) will centralise data access for AI development while ensuring GDPR compliance.
Partnerships: Collaborations with tech firms (e.g., Microsoft Azure, Google Cloud) and startups (e.g., Babylon Health) will accelerate AI deployment.
Ethical Frameworks: The NHS AI Lab’s Ethics Council will ensure bias-free algorithms, critical for diverse populations.
Key Challenges:
Ensuring equity in AI access across rural and deprived areas.
Managing public trust amid data privacy concerns, especially after controversies like the 2021 GP data-sharing opt-out backlash.
Scaling AI across 42 ICSs with varying digital maturity.
Long-Term (2035–2040): AI as a Near-Autonomous Co-Clinician
AI will function as a near-autonomous partner, managing complex care pathways under clinician oversight, with seamless integration across the NHS.
Holistic Care Management:
Chronic Disease Oversight: AI will manage conditions like diabetes or COPD, adjusting medications, scheduling tests, and coordinating multidisciplinary teams via EHRs.
Mental Health Support: AI-driven chatbots, integrated with NHS Talking Therapies, will provide 24/7 cognitive behavioural therapy, escalating to human clinicians when needed.
Example: A patient with heart failure could have their EHR-linked wearable data monitored by AI, which adjusts diuretics and alerts cardiologists to anomalies.
Precision Medicine at Scale:
Genomic Integration: The NHS Genomic Medicine Service, expanded to all trusts, will feed data into AI models for tailored therapies (e.g., cancer immunotherapies).
Social Determinants: AI will incorporate socioeconomic data to address health inequalities, recommending community-based interventions.
Global and Regional Learning:
Federated Learning: AI models will train on anonymised NHS data while sharing insights globally, improving accuracy without compromising privacy.
Real-Time Epidemiology: AI will predict and mitigate regional health crises, e.g., antimicrobial resistance spikes.
Clinician-AI Symbiosis:
Voice-Driven Workflows: Clinicians will interact with AI via natural language, asking, “What’s the best next step for this patient?” and receiving evidence-based options.
Continuous Feedback: AI will learn from clinician overrides, refining suggestions to align with NHS protocols and local practices.
Key Enablers:
Quantum-Resistant Security: As quantum computing emerges, NHS EHRs will adopt advanced encryption to protect patient data.
National AI Infrastructure: A centralised NHS AI platform, built on cloud and edge computing, will ensure low-latency access in remote areas.
Policy Support: The NHS Long Term Plan’s successor will mandate AI adoption, with funding tied to digital maturity.
Key Challenges:
Balancing AI autonomy with clinician accountability to avoid legal and ethical pitfalls.
Sustaining funding amid competing priorities (e.g., workforce expansion).
Addressing global competition for AI talent, as the NHS competes with private sectors.
Ethical and Practical Considerations
Bias and Equity: AI must be trained on diverse NHS data to avoid disparities, e.g., ensuring algorithms work for ethnic minorities or rural populations. The NHS’s Algorithmic Impact Assessment framework will be critical.
Patient Trust: Transparent communication via the NHS App will explain AI’s role, with opt-out options for data use. Blockchain-based data control could empower patients.
Workforce Impact: AI must complement, not replace, staff. Upskilling programs will help clinicians embrace AI as a tool, not a threat.
Regulation: The MHRA and NHS England will evolve standards for AI safety, ensuring compliance with GDPR and the UK’s AI Regulation Bill (proposed 2024).
Current NHS AI Initiatives (2025 Context)
NHS AI Lab: Funds projects like AI for lung cancer detection (e.g., Optellum’s virtual biopsy tool).
Great Ormond Street Hospital: Uses AI to predict paediatric patient deterioration.
Partnerships: Collaborations with Google Health, Microsoft, and startups like Behold.ai for radiology AI.
Projected Outcomes by 2040
Clinical Impact: 20–30% reduction in diagnostic errors; 15–20% faster treatment initiation for urgent cases (e.g., stroke).
Efficiency: 30–40% reduction in administrative time for clinicians; 10–15% shorter waiting lists for elective care.
Equity: AI-driven interventions reduce health disparities by 10–15% in underserved areas.
Cost Savings: £5–10 billion annually saved through optimised workflows and preventive care, reinvested into frontline services.
Risks and Mitigation
Data Privacy Breaches: Robust cybersecurity (e.g., zero-trust architecture) and patient-controlled data access will minimise risks.
Over-Reliance on AI: Training and clear guidelines will ensure clinicians remain in control.
Digital Divide: Mobile NHS App access and low-cost wearables will bridge gaps in rural and low-income areas.
Over the next 15 years, AI as a co-clinician in the NHS will evolve from a supportive tool to a near-autonomous partner, deeply embedded in interoperable EHRs. It will enhance diagnostics, personalize care, and optimize resources while addressing inequalities. Success hinges on scalable infrastructure, ethical governance, and workforce buy-in, leveraging the NHS’s centralized model to deploy AI equitably.
Nelson Advisors > HealthTech M&A
Nelson Advisors specialise in mergers, acquisitions and partnerships for Digital Health, HealthTech, Health IT, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk
We work with our clients to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value and investment returns. Email lloyd@nelsonadvisors.co.uk
Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
We share our views on the latest Healthcare Technology mergers, acquisitions and partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
#HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #Cybersecurity #HealthcareAI #Partnerships #NHS #UK #Europe #USA #Canada
Nelson Advisors
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Contact Us
Meet Us
Digital Health Rewired > 18-19th March 2025
NHS ConfedExpo > 11-12th June 2025
HLTH Europe > 16-19th June 2025
HIMSS AI in Healthcare > 10-11th July 2025

Comments